Inventor · disambiguated record
Matthew Mcclorey
Also filed as: MCCLOREY MATTHEW
18 granted patents·14 pending applications·116 citations·filing 2016–2024
93Inventor score
Files withCRITITECH INC32
Top patents by PatentIndex Score
32 records- 0197US9814685B2Taxane particles and their useCRITITECH INC·Filed 2016·Granted Nov 14, 2017·40 cites·18 claims
- 0296US10729673B2Taxane particles and their useCRITITECH INC·Filed 2020·Granted Aug 4, 2020·11 cites·22 claims
- 0396US9918957B2Methods for making compound particlesCRITITECH INC·Filed 2017·Granted Mar 20, 2018·23 cites·18 claims
- 0495US10507195B2Taxane particles and their useCRITITECH INC·Filed 2018·Granted Dec 17, 2019·18 cites·28 claims
- 0594US10507181B2Methods for treating lung disordersCRITITECH INC·Filed 2019·Granted Dec 17, 2019·10 cites·23 claims
- 0694US10398646B2Methods for treating lung disordersCRITITECH INC·Filed 2018·Granted Sep 3, 2019·10 cites·20 claims
- 0791US11123322B2Taxane particles and their useCRITITECH INC·Filed 2019·Granted Sep 21, 2021·2 cites·18 claims
- 0890US2025186390A1Taxane Particles and Their UseCRITITECH INC·Filed 2024·Application pending·0 cites
- 0986US12329858B2Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancerCRITITECH INC·Filed 2024·Granted Jun 17, 2025·0 cites·19 claims
- 1086US10993927B2Taxane particles and their useCRITITECH INC·Filed 2020·Granted May 4, 2021·1 cites·18 claims
- 1184US11058639B2Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancerCRITITECH INC·Filed 2020·Granted Jul 13, 2021·1 cites·24 claims
- 1283US12128131B2Treatment of epithelial cysts by intracystic injection of antineoplastic particlesCRITITECH INC·Filed 2023·Granted Oct 29, 2024·0 cites·18 claims
- 1380US11918691B2Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancerCRITITECH INC·Filed 2023·Granted Mar 5, 2024·0 cites·14 claims
- 1480US11737972B2Treatment of epithelial cysts by intracystic injection of antineoplastic particlesCRITITECH INC·Filed 2022·Granted Aug 29, 2023·0 cites·18 claims
- 1579US2021393569A1Taxane Particles and Their UseCRITITECH INC·Filed 2021·Application pending·0 cites
- 1675US11160754B2Methods for treating lung disordersCRITITECH INC·Filed 2019·Granted Nov 2, 2021·0 cites·25 claims
- 1774US11583499B2Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancerCRITITECH INC·Filed 2021·Granted Feb 21, 2023·0 cites·21 claims
- 1874US2024226116A1Glucocorticoid Particles and Their UseCRITITECH INC·Filed 2024·Application pending·0 cites
- 1974US2020405684A1Taxane Particles and Their UseCRITITECH INC·Filed 2020·Application pending·0 cites
- 2073US11523983B2Treatment of epithelial cysts by intracystic injection of antineoplastic particlesCRITITECH INC·Filed 2021·Granted Dec 13, 2022·0 cites·18 claims
- 2170US2019254957A1Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic ParticlesCRITITECH INC·Filed 2019·Application pending·0 cites
- 2270US2022096423A1Treatment of Bladder Cancer by Local Administration of Taxane ParticlesCRITITECH INC·Filed 2021·Application pending·0 cites
- 2367US11931368B2Glucocorticoid “nintedanib” particles and their useCRITITECH INC·Filed 2018·Granted Mar 19, 2024·0 cites·8 claims
- 2467US2019209515A1Treatment of Bladder Cancer by Intratumoral Injection of Taxane ParticlesCRITITECH INC·Filed 2019·Application pending·0 cites
- 2567US2019209514A1Treatment of Bladder Cancer by Local Administration of Taxane ParticlesCRITITECH INC·Filed 2019·Application pending·0 cites
- 2666US11104663B2Ciprofloxacin polymorph and its useCRITITECH INC·Filed 2018·Granted Aug 31, 2021·0 cites·19 claims
- 2763US2016374953A1Methods for Making Compound ParticlesCRITITECH INC·Filed 2016·Application pending·0 cites
- 2863US2021387961A1Ciprofloxacin polymorph and its useCRITITECH INC·Filed 2021·Application pending·0 cites
- 2961US2021214683A1Methods for isolating tumor-specific immune cells from a subject for adoptive cell therapy and cancer vaccinesCRITITECH INC·Filed 2019·Application pending·0 cites
- 3051US2019365700A1Methods for Isolating Tumor-Specific Immune Cells from a Subject for Adoptive Cell Therapy and Cancer VaccinesCRITITECH INC·Filed 2019·Application pending·0 cites
- 3144US2019365699A1Treatment of Kidney Tumors by Intratumoral Injection of Taxane ParticlesCRITITECH INC·Filed 2019·Application pending·0 cites
- 3244US2019365698A1Use of Antineoplastic Agents to Stimulate the Immune System for Treatment of CancerCRITITECH INC·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →